eGenesis
also invests · investor profileFounded 2015 · 154 employees on LinkedIn · 7 known investors
Find your way into eGenesis
Sign up to see every warm intro you have to eGenesis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the eGenesis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
Founders & leadership

Investors · 7
How we know: Alta Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Altium Capital's portfolio page · Not right? Tell us
How we know: Fresenius Medical Care Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Khosla Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Founder mafia
2 people who came through eGenesis went on to found or lead other companies.
Related companies · 3
Companies working in the same space as eGenesis.
Frequently asked questions
- What does eGenesis do?
- eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
- Who are eGenesis's investors?
- eGenesis's investors include Alta Partners, Altium Capital, Eisai Innovation, Inc., Fresenius Medical Care Ventures, Khosla Ventures, Lux Capital, ARCH Venture Partners.




